Navigation Links
Physician-scientist urges improved drug regulation to ensure heart safety of non-heart drugs
Date:12/28/2007

be standardized for all observers before the drug is administered to any patient. (Currently, for drugs not intended for heart problems, cardiovascular effects often are assessed only minimally, generally in later phases of drug development. And, the definition of adverse events is left up to each observer individually, limiting the strength of conclusions about cardiovascular safety.)
  • Regulatory bodies should be given the authority to mandate continuing evaluation of drug effects, even after approval for marketing. This will allow updates in drug labeling to increase the precision with which doctors and patients can know the relation of benefit and risk, enabling the best decisions about selection of treatment strategies.
  • Regulatory bodies should be empowered to withdraw approval if mandated post-marketing studies are not performed. Currently, the FDA, for example, does not have such authority.
  • If the drug is likely to be used by people who have relatively high cardiovascular risk (as, for example, might be the case with a drug for arthritis), at least one study of the drug's beneficial effects should be carried out among such patients, not only in low risk people as is now commonly the case.
  • Analysis plans should be designed to incorporate all data collected during development, including results of so-called observational studies (which do not employ randomization to eliminate study bias, and which do not employ "control" groups for comparison) in order to increase statistical power to find problems if they exist. Currently, this kind of analysis plan is not usually employed.

    Dr. Borer's presentation was made at the recent annual meeting of the European Society of Cardiology in Vienna, and was drawn in part from his article in the Aug. 2007 issue of the European Heart Journal. This paper summarizes the conclusions of a group of co-authors -- including cardiologists, biostatisticians, FDA and EMEA (European Medicines Agency H
    '/>"/>


  • Contact: Emily Berlanstein
    eab2007@med.cornell.edu
    212-821-0560
    New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
    Source:Eurekalert

    Page: 1 2 3

    Related biology news :

    1. Physician-scientists seek solutions to reproductive problems related to chromosomal variations
    2. Improved e-jet printing provides higher resolution and more versatility
    3. In-vitro fertilization improved with 3-D/4-D-guided embryo transfer and new placement target
    4. UCR researchers awarded nearly $1.7M to develop improved cowpea varieties
    5. Gene regulation, not just genes, is what sets humans apart
    6. Evolution is driven by gene regulation
    7. Muscle mass: Scientists identify novel mode of transcriptional regulation during myogenesis
    8. Scientists find clue to mechanisms of gene signaling and regulation
    9. Gene regulation in humans is closer than expected to simple organisms
    10. The importance of gene regulation for common human disease
    11. Einstein researcher receives NIH grant to explore epigenetic regulation of the human genome
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/28/2014)... Yale University researchers have identified a handful of bacterial ... as Crohn,s disease and ulcerative colitis, using patients, own ... are published Aug. 28 in the journal Cell ... intestinal microbiota, which plays a critical role in the ... only a small number of bacterial species affect a ...
    (Date:8/28/2014)... researcher and his collaborators have developed an online analytic ... of re-engineering cells for biomedical investigation. CellNet is a ... aid stem cell engineering. Details of CellNet and its ... back-to-back papers in the journal Cell . , ... for all types of cell-based investigations and can potentially ...
    (Date:8/28/2014)...  Privacy Advocate and Senior Staff Attorney at the ... the lineup of biometric and mobile commerce experts set ... Summit in Tampa, Florida on ... include Steven Rahman, Director, Technology and Strategy at Samsung, and ... theme of this year,s event is Mobility at the ...
    Breaking Biology News(10 mins):Yale study identifies possible bacterial drivers of IBD 2New tool aids stem cell engineering for medical research 2Biometrics UnPlugged Welcomes the Electronic Frontier Foundation's Jennifer Lynch to the Mobility at the Crossroads of Commerce and Privacy Summit 2
    ... in the form of reduced snowfall in mountains is ... communities through the increased ability of elk to stay at ... groundbreaking study in Nature Climate Change . , ... only showed that the abundance of deciduous trees and their ...
    ... children delivered by cesarean section have an increased risk of ... Cohort Study (MoBa) suggests that children delivered by cesarean section ... three. This was particularly seen among children without a hereditary ... than 37 000 participants in the MoBa study were used ...
    ... frequently caused by smoking and exposure to carcinogens in the ... of cancer in men,and women in the U.S. More than ... or less and have not invaded the muscle layer. At ... the burning away of tumors with high energy electricity (fulguration). ...
    Cached Biology News:Dramatic links found between climate change, elk, plants, and birds 2Tapping the body's own defenses, researchers look to cutting-edge gene therapy for bladder cancer 2
    (Date:8/29/2014)... 2014 /PRNewswire/ - iCo Therapeutics ("iCo" or "the ... results for the six months ended June 30, ... Canadian dollars and presented under International Financial Reporting ... , Announced top-line results related to ... for subjects enrolled in the Phase 2 iDEAL ...
    (Date:8/29/2014)... MA, San Antonio, TX (PRWEB) August 29, 2014 ... ISO 9001:2008 and ISO 13485:2003 certified, GAMP® 5 ... has been awarded an international Phase II clinical ... with non-Hodgkin’s lymphoma. , Throughout this trial, Intrinsic ... including, but not limited to, protocol and charter ...
    (Date:8/28/2014)... Ind. A new research platform uses ... of tiny structures undergoing stress and heating, ... improve designs for microelectronics and batteries., This ... information about how heating and the surface ... properties. Researchers have discussed the merits of ...
    (Date:8/28/2014)... , Aug. 28, 2014   SunTrust Robinson ... three industry veterans to its equity research team ... "Our ongoing expansion in equity research demonstrates our ... unique insights to enhance their investment decision making," ... at STRH.  "We continue to make significant investments ...
    Breaking Biology Technology:iCo Therapeutics Announces Second Quarter 2014 Financial Results 2iCo Therapeutics Announces Second Quarter 2014 Financial Results 3iCo Therapeutics Announces Second Quarter 2014 Financial Results 4Intrinsic Imaging Awarded Phase II Clinical Trial to Assess New Treatment for Non-Hodgkin’s Lymphoma 2New analytical technology reveals 'nanomechanical' surface traits 2New analytical technology reveals 'nanomechanical' surface traits 3SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 2SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 3
    ... Oct. 4 Auxogyn, Inc., a privately held medical ... that it acquired an exclusive license from Stanford University ... medical practitioners in the field of assisted reproduction to ... fertilization (IVF) procedures. The technology licensed from ...
    ... CryoLife, Inc. (NYSE: CRY ), an implantable ... today that it has appointed David P. Lang as ...  In this newly created position, Mr. Lang will have ... distribution strategies for PerClot, a novel hemostatic agent that ...
    ... (SIX: RO, ROG; OTCQX: RHHBY) announced today that the cobas ... 201 system is now available with the CE Mark. It ... human genotypes of parvovirus B19 (B19V) and hepatitis A virus (HAV) ... amplification technology (NAT) test which simultaneously quantifies B19V genotypes 1, 2 ...
    Cached Biology Technology:Auxogyn Licenses Non-invasive Embryo Assessment Technology From Stanford University 2David P. Lang Appointed Vice President of CryoLife International, Inc. 2David P. Lang Appointed Vice President of CryoLife International, Inc. 3David P. Lang Appointed Vice President of CryoLife International, Inc. 4First Duplex Test for Parvovirus B19 and Hepatitis A Virus Increases Safety of Human Plasma and Plasma Products 2First Duplex Test for Parvovirus B19 and Hepatitis A Virus Increases Safety of Human Plasma and Plasma Products 3
    ...
    ... requiring mass detection but not structural ... Mass spectrometer is ideally suited for ... high performance mass analysis. Typical ... protein detection, micro-satellite DNA characterization and ...
    Rat Aortic Smooth Muscle Cells (RAOSMC) (>500,000 cells)...
    Rat Dermal Fibroblasts (RDF) (>500,000 cells)...
    Biology Products: